YUCAIPA, Calif., Dec. 18, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries announced today that the company has received new distribution partners and made sales at the American Association of Respiratory Care (AARC) 55th international respiratory congress in San Antonio-Texas during December 5th through the 7th, 2009.
Ingen was an exhibitor at the American Association of Respiratory Care (AARC) 55th international respiratory congress earlier this month. The company introduced the Oxyview Nasal Cannula to this year's attendees. With more than 47,000 members nationwide, the AARC is the only professional society for respiratory therapists in hospitals and with home care companies, managers of respiratory and cardiopulmonary services, and educators who provide respiratory care training.
The company gave away and sold all of the Oxyview Nasal Cannulas that were available at the show and closed several new distribution contracts.
"All of the samples and marketing material were taken by the end of the convention. More than 8 new distributors were signed on, and several respiratory equipment manufacturers had agreed to include the Oxyview and Oxyview Nasal Cannula with their product line. Thousands of members took home samples, brochures and publications about our products. We are seeing a strong increase in revenues, and expect this trend to continue over the next several years," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.
http://www.medox-oxyview.com/Events.html
About Ingen: Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009, the company introduced the new Oxyview Nasal Cannula for adult, children and infants. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, according to the World Health Organization. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.